ENTITY
Glenmark Pharmaceuticals

Glenmark Pharmaceuticals (GNP IN)

167
Analysis
Health Care • India
Glenmark Pharmaceuticals Ltd., is a pharmaceutical company. The Company develops generic drugs for inflammation, metabolic disorders, and pain.
more
bullish•Tunas Baru Lampung
•25 Nov 2020 08:59

Morning Views Asia: Glenmark Pharmaceuticals, Lifestyle International Holdings, Tunas Baru Lampung

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region,...

Logo
230 Views
Share
•24 Nov 2020 08:49

Morning Views Asia: Glenmark Pharmaceuticals, Times China, Tower Bersama Infrastructure

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region,...

Logo
262 Views
Share
•04 Nov 2020 15:53

Asia HY Monthly - Returns And Volatility For Unrated Chinese Issuers (2020) - Lucror Analytics

In this month’s “In-Focus” section, we provide an update to our 2018 analysis of returns and volatility for unrated Chinese issuers. Since our...

Logo
230 Views
Share
•30 Oct 2020 17:17

Asia HY Trade Book - October 2020 - Lucror Analytics

The Asia HY Trade Book for the month of October includes a summary of our recommendations, as well as our high-conviction ideas. The report also...

Logo
205 Views
Share
•02 Oct 2020 15:35

Asia HY Monthly - China's Three Red Lines - Lucror Analytics

In this month’s “In-Focus” section, we consider China’s new Three Red Lines leverage guidelines for developers, which have been rolled out on a...

Logo
274 Views
Share
x